+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ophthalmology Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery

  • ID: 5032520
  • Report
  • May 2020
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Adcock Ingram
  • Cristalia
  • ERC Labs
  • Johnson & Johnson
  • Pfizer Inc.
  • Shire

Ophthalmology Drugs Global Market Opportunities and Strategies to 2030: COVID 19 Impact and Recovery report provides the strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest-growing market for the ophthalmology drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global ophthalmology drugs global market opportunities and strategies to 2030: COVID 19 impact and recovery report answers all these questions and many more.

The report covers the following chapters:

1. Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
2. Report Structure – This section gives the structure of the report and the information covered in the various sections.
3. Introduction – The introduction section of the report gives a brief introduction about segmentation by geography and segmentation by drug type, by therapeutic class and by formulation.
4. Market Characteristics – The market characteristics section of the report defines and explains the ophthalmology drugs market. This chapter also defines and describes goods and related services covered in the report.
5. Product Analysis – The product analysis section of the report describes the leading products in the ophthalmology drugs market along with key features and differentiators for those products.
6. Supply Chain – The supply chain section of the report defines and explains the key players in the ophthalmology drugs industry supply chain.
7. Customer Information – This chapter covers recent customers’ trends/preferences in the global ophthalmology drugs market.
8. Trends And Strategies – This chapter describes the major trends shaping the global ophthalmology drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
9. Leading Ophthalmologic Drug Therapies - This section describes the leading drug therapies in the ophthalmology drugs market.
10. Gene Therapy In Ophthalmology - This section describes the scenario of gene therapy in the field of ophthalmology. It describes the current state of the research and development and advances in gene therapies, and the potential of gene therapy in ophthalmology in the near- and long-term.
11. Unmet Needs In Ophthalmology Drugs Market - This section describes unmet needs in the ophthalmology drugs market.
12. Impact of COVID-19 On Ophthalmology Drugs Market - This section describes the impact of COVID-19 on the ophthalmology drugs market.
13. Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019-2023) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
14. Regional Analysis – This section contains the historic (2015-2019) and forecast (2019-2023) market value and growth and market share comparison by region.
15. Segmentation – This section contains the market values (2015-2023) and analysis for different segments.
16. Global Macro Comparison – The global ophthalmology drugs market comparison with macro-economic factors gives the ophthalmology drugs market size, percentage of GDP, and average ophthalmology drugs market expenditure.
17. Regional Market Size and Growth – This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023) market value, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies. This information is also given for China.
18. Competitive Landscape – This section covers details on the competitive landscape of the global ophthalmology drugs market, estimated market shares and company profiles for the leading players.
19. Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
20. Market Background – This section describes the pharmaceutical drugs market of which the ophthalmology drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2015-19 and 2019-23 values, and regional and country analyses for the personal services market.
21. Market Opportunities And Strategies – This section includes market opportunities and strategies based on the findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
22. Conclusions And Recommendations – This section includes conclusions and recommendations based on the findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
23. Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • By Drug Type: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs
  • By Prescription Type: OTC Drugs; Prescription Drugs
  • By Distribution Channel: Hospital Pharmacies; Eye Health Clinics; Retail Pharmacies; Online Pharmacies
  • By Type Variation: Branded Drugs; Generic Drugs

Companies Mentioned: Novartis AG; Regeneron Pharmaceuticals Inc.; Allergan Plc.; Bayer AG; Santen Pharmaceutical Co. Ltd.

Countries: China, Australia, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Canada, Mexico, USA, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Czech Republic, Poland, Romania, Russia, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast, three years further forecast, and six years further forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adcock Ingram
  • Cristalia
  • ERC Labs
  • Johnson & Johnson
  • Pfizer Inc.
  • Shire

1. Ophthalmology Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1.1. Segmentation By Geography
6.1.2. Segmentation By Drug Type
6.1.3. Segmentation By Prescription Type
6.1.4. Segmentation By Drug Variation
6.1.5. Segmentation By Distribution Channel

7. Ophthalmology Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Drug Type
7.2.1. Antiglaucoma Drugs
7.2.2. Dry Eye Medication
7.2.3. Other Ophthalmological Drugs
7.3. Market Segmentation By Prescription Type
7.3.1. OTC Drugs
7.3.2. Prescription Drugs
7.4. Market Segmentation By Drug Variation
7.4.1. Branded Drugs
7.4.2. Generic Drugs
7.5. Market Segmentation By Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2. Eye Health Clinics
7.5.3. Retail Pharmacies
7.5.4. Online Pharmacies

8. Ophthalmology Drugs Market Product Analysis – Product Examples
8.1. Leading Products
8.1.1. Novartis AG
8.1.2. Roche
8.1.3. Allergan
8.1.4. Valeant (Bausch+Lomb)
8.1.5. Aerie Pharmaceuticals Inc.
8.1.6. Regeneron Pharmaceuticals Inc.
8.1.7. Pfizer, Inc.
8.1.8. Santen Pharmaceutical Co., Ltd
8.1.9. Genentech, Inc.
8.1.10. Sun Pharmaceuticals Industries, Ltd.
8.2. New Products Approved
8.2.1. Sun
8.2.2. Pharmaceuticals Industries, Ltd.
8.2.3. Dompé
8.2.4. Farmaceutici SpA
8.2.5. EyePoint
8.2.6. Pharmaceuticals,
8.2.7. Inc.
8.2.8. Ivantis
8.2.9. Sun
8.2.10. Pharmaceuticals Industries, Ltd
8.2.11. Regeneron
8.2.12. Kala
8.2.13. Pharmaceuticals
8.2.14. Ocular Therapeutix
8.2.15. EyePoint Pharmaceuticals
8.2.16. Novartis
8.2.17. Aerie Pharmaceuticals
8.2.18. Merz Pharma

9. Ophthalmology Drugs Market Supply Chain Analysis
9.1. Raw Material Suppliers
9.2. Contract Research Organization (CRO)
9.3. Ophthalmology Drugs Manufacturer
9.3.1. Drug Discovery
9.3.2. Preclinical And Clinical Trials
9.3.3. Patents Upon Discovery And Approval
9.3.4. Drug Manufacturing
9.4. Contract Manufacturing Organization (CMO)
9.5. Wholesalers/Distributors
9.6. Retailers (Pharmacies) And Hospitals
9.7. Ophthalmologists And Optometrists
9.8. End-Users

10. Ophthalmology Drugs Market Customer Information
10.1. Loss Of Vision Is The Major Concern For Glaucoma Patients
10.2. Majority Of The Patients Do not Seek Preventive Eye Care
10.3. Impact Of Dry Eye Disease (DED) On Patients’ Quality Of Life
10.4. Two-thirds Of Americans Suffer From Eye Problems
10.5. Americans Taking More Prescription Drugs than Ever
10.6. Increasing Intake of Prescription Drugs

11. Ophthalmology Drugs Market Trends And Strategies
11.1. Innovative Drugs To Reduce Postoperative Inflammation And Pain
11.2. New Rho-kinase Inhibitors for Glaucoma
11.3. Development Of New Mode Of Delivery Systems
11.4. Single Dose Preservative Free Eye Drops
11.5. New Product Development
11.6. Development Of Combination Therapies
11.7. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Dry Eye Treatment
11.8. Rising Research And Collaborations
11.9. Global Expansion And Acquisitions

12. Leading Ophthalmologic Drug Therapies

13. Gene Therapy In Ophthalmology
13.1. Current Scenario Of Research And Development In Gene Therapy
13.2. Near-Term Potential
13.3. Long-Term Potential

14. Unmet Needs In Ophthalmology Drugs Market

15. Impact of COVID-19 On Ophthalmology Drugs Market

16. Global Ophthalmology Drugs Market Size And Growth
16.1. Historic Market Growth, 2015 – 2019, Value ($ Million)
16.1.1. Drivers Of The Market 2015 – 2019
16.1.2. Aging Population -
16.1.3. Restraints On The Market 2015 – 2019
16.2. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
16.2.1. Drivers Of The Market 2019 – 2023
16.2.2. Restraints On The Market 2019 – 2023

17. Ophthalmology Drugs Market, Regional Analysis
17.1. Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
17.2. Global Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Region
17.3. Global Ophthalmology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region

18. Global Ophthalmology Drugs Market Segmentation
18.1. Global Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
18.1.1. Antiglaucoma Drugs
18.1.2. Dry Eye Medication
18.1.3. Other Ophthalmology Drugs
18.2. Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
18.2.1. Retail Pharmacies
18.2.2. Hospital Pharmacies
18.2.3. Eye Health Clinics
18.2.4. Online Pharmacies
18.3. Global Ophthalmology Drugs Market, Segmentation By Type Of Prescription, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
18.3.1. OTC Drugs
18.3.2. Prescription Drugs
18.4. Global Ophthalmology Drugs Market, Segmentation By Drug Variation, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
18.4.1. Branded Drugs
18.4.2. Generic Drugs

19. Global Ophthalmology Drugs Market Comparison with Macro Economic Factors
19.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global
19.2. Per Capita Average Ophthalmology Drugs Market Expenditure, Global

20. Asia-Pacific Ophthalmology Drugs Market
20.1. Asia-Pacific Ophthalmology Drugs Market Overview
20.2. Region Information
20.3. Market Information
20.4. Background Information
20.5. New Drug Approval
20.6. Government Initiatives
20.7. Regulations
20.8. Regulatory Bodies
20.9. Major Associations
20.10. Corporate Tax Structure
20.11. Taxes Levied
20.12. Investments
20.13. Major Companies
20.14. Asia-Pacific Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.15. Asia-Pacific Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.16. Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.17. Asia- Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.18. Asia-Pacific Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
20.19. Asia-Pacific Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
20.20. Asia-Pacific Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
20.21. Asia-Pacific Ophthalmology Drugs Market Metrics
20.21.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Asia-Pacific Major Countries
20.22. Asia-Pacific Ophthalmology Drugs Market: Country Analysis
20.23. Australia Ophthalmology Drugs Market
20.24. Australia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.25. Australia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.26. Australia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.27. Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.28. China Ophthalmology Drugs Market
20.29. China Ophthalmology Drugs Market Overview
20.30. Country Information
20.31. Market Information
20.32. Background Information
20.33. New Drug Approval
20.34. Government Initiatives
20.35. Regulations
20.36. Regulatory Bodies
20.37. Major Associations
20.38. Tax Levied
20.39. Corporate Tax Structure
20.40. Investments
20.41. Major Companies
20.42. China Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.43. China Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.44. China Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.45. China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.46. Hong Kong Ophthalmology Drugs Market
20.47. Hong Kong Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.48. Hong Kong Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.49. India Ophthalmology Drugs Market
20.50. India Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.51. India Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.52. India Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.53. India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.54. Indonesia Ophthalmology Drugs Market
20.55. Indonesia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.56. Indonesia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.57. Indonesia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.58. Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.59. Japan Ophthalmology Drugs Market
20.60. Japan Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.61. Japan Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.62. Japan Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.63. Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.64. Malaysia Ophthalmology Drugs Market
20.65. Malaysia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.66. Malaysia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.67. New Zealand Ophthalmology Drugs Market
20.68. New Zealand Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.69. New Zealand Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.70. Philippines Ophthalmology Drugs Market
20.71. Philippines Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.72. Philippines Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.73. Singapore Ophthalmology Drugs Market
20.74. Singapore Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.75. Singapore Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.76. South Korea Ophthalmology Drugs Market
20.77. South Korea Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.78. South Korea Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.79. South Korea Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.80. South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.81. Thailand Ophthalmology Drugs Market
20.82. Thailand Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.83. Thailand Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
20.84. Vietnam Ophthalmology Drugs Market
20.85. Vietnam Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
20.86. Vietnam Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

21. Western Europe Ophthalmology Drugs Market
21.1. Western Europe Ophthalmology Drugs Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. Background Information
21.1.4. New Drug Approvals
21.1.5. Government Initiatives
21.1.6. Regulations
21.1.7. Major Associations
21.1.8. Taxes Levied
21.1.9. Corporate Tax Structure
21.1.10. Investments
21.1.11. Major Companies
21.2. Western Europe Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.3. Western Europe Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.4. Western Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.5. Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.6. Western Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
21.7. Western Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
21.8. Western Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
21.9. Western Europe Ophthalmology Drugs Market Metrics
21.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Western Europe Major Countries
21.10. Western Europe Ophthalmology Drugs Market: Country Analysis
21.11. Austria Ophthalmology Drugs Market
21.12. Austria Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.13. Austria Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.14. Belgium Ophthalmology Drugs Market
21.15. Belgium Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.16. Belgium Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.17. Denmark Ophthalmology Drugs Market
21.18. Denmark Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.19. Denmark Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.20. Finland Ophthalmology Drugs Market
21.21. Finland Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.22. Finland Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.23. France Ophthalmology Drugs Market
21.24. France Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.25. France Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.26. France Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.27. France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.28. Germany Ophthalmology Drugs Market
21.29. Germany Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.30. Germany Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.31. Germany Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.32. Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.33. Ireland Ophthalmology Drugs Market
21.34. Ireland Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.35. Ireland Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.36. Italy Ophthalmology Drugs Market
21.37. Italy Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.38. Italy Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.39. Italy Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.40. Italy Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.41. Netherlands Ophthalmology Drugs Market
21.42. Netherlands Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.43. Netherlands Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.44. Norway Ophthalmology Drugs Market
21.45. Norway Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.46. Norway Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.47. Portugal Ophthalmology Drugs Market
21.48. Portugal Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.49. Portugal Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.50. Spain Ophthalmology Drugs Market
21.51. Spain Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.52. Spain Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.53. Spain Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.54. Spain Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.55. Sweden Ophthalmology Drugs Market
21.56. Sweden Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.57. Sweden Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.58. Switzerland Ophthalmology Drugs Market
21.59. Switzerland Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.60. Switzerland Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.61. UK Ophthalmology Drugs Market
21.62. UK Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.63. UK Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.64. UK Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.65. UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

22. Eastern Europe Ophthalmology Drugs Market
22.1. Eastern Europe Ophthalmology Drugs Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. Background Information
22.1.4. New Drug Approvals
22.1.5. Government Initiatives
22.1.6. Regulations
22.1.7. Regulatory Bodies
22.1.8. Major Associations
22.1.9. Taxes Levied
22.1.10. Corporate Tax Structure
22.1.11. Investments
22.1.12. Major Companies
22.2. Eastern Europe Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.3. Eastern Europe Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.4. Eastern Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
22.5. Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
22.6. Eastern Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
22.7. Eastern Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
22.8. Eastern Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
22.9. Eastern Europe Ophthalmology Drugs Market Metrics
22.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Eastern Europe Major Countries
22.10. Eastern Europe Ophthalmology Drugs Market: Country Analysis
22.11. Czech Republic Ophthalmology Drugs Market
22.12. Czech Republic Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.13. Czech Republic Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.14. Poland Ophthalmology Drugs Market
22.15. Poland Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.16. Poland Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.17. Romania Ophthalmology Drugs Market
22.18. Romania Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.19. Romania Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.20. Russia Ophthalmology Drugs Market
22.21. Russia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.22. Russia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.23. Russia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
22.24. Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

23. North America Ophthalmology Drugs Market
23.1. North America Ophthalmology Drugs Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. Background Information
23.1.4. New Drug Approval
23.1.5. Government Initiatives
23.1.6. Regulations
23.1.7. Regulatory Bodies
23.1.8. Major Associations
23.1.9. Tax Levied
23.1.10. Corporate Tax Structure
23.1.11. Investments
23.1.12. Major Companies
23.2. North America Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
23.3. North America Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
23.4. North America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
23.5. North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
23.6. North America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
23.7. North America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
23.8. North America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
23.9. North America Ophthalmology Drugs Market Metrics
23.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, North America Major Countries
23.9.2. North America Ophthalmology Drugs Market: Country Analysis
23.10. Canada Ophthalmology Drugs Market
23.11. Canada Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
23.12. Canada Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
23.13. Mexico Ophthalmology Drugs Market
23.14. Mexico Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
23.15. Mexico Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
23.16. USA Ophthalmology Drugs Market Overview
23.16.1. Country Information
23.16.2. Market Information
23.16.3. Background Information
23.16.4. New Drug Approval
23.16.5. Government Initiatives
23.16.6. Regulations
23.16.7. Regulatory Bodies
23.16.8. Major Associations
23.16.9. Tax Levied
23.16.10. Corporate Tax Structure
23.16.11. Investments
23.16.12. Major Companies
23.17. USA Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
23.18. USA Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
23.19. USA Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
23.20. USA Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

24. South America Ophthalmology Drugs Market
24.1. South America Ophthalmology Drugs Market Overview
24.1.1. Region Information
24.1.2. Market Information
24.1.3. Background Information
24.1.4. New Drug Approval
24.1.5. Government Initiatives
24.1.6. Regulations
24.1.7. Regulatory Bodies
24.1.8. Major Associations
24.1.9. Tax Levied
24.1.10. Corporate Tax Structure
24.1.11. Investments
24.1.12. Major Companies
24.2. South America Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.3. South America Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
24.4. South America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
24.5. South America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
24.6. South America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
24.7. South America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
24.8. South America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
24.9. South America Ophthalmology Drugs Market Metrics
24.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, South America Major Countries
24.10. South America Ophthalmology Drugs Market: Country Analysis
24.11. Argentina Ophthalmology Drugs Market
24.12. Argentina Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.13. Argentina Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
24.14. Chile Ophthalmology Drugs Market
24.15. Chile Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.16. Chile Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
24.17. Colombia Ophthalmology Drugs Market
24.18. Colombia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.19. Colombia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
24.20. Brazil Ophthalmology Drugs Market
24.21. Brazil Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.22. Brazil Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
24.23. Brazil Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
24.24. Brazil Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
24.25. Peru Ophthalmology Drugs Market
24.26. Peru Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.27. Peru Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
24.28. Venezuela Ophthalmology Drugs Market
24.29. Venezuela Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.30. Venezuela Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

25. Middle East Ophthalmology Drugs Market
25.1. Middle East Ophthalmology Drugs Market Overview
25.1.1. Region Information
25.1.2. Market Information
25.1.3. Background Information
25.1.4. New Drug Approvals
25.1.5. Government Initiatives
25.1.6. Regulations
25.1.7. Regulatory Bodies
25.1.8. Major Associations
25.1.9. Taxes Levied
25.1.10. Corporate Tax Structure
25.1.11. Investments
25.1.12. Major Companies
25.1.13. Competitive Landscape
25.2. Middle East Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
25.3. Middle East Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
25.4. Middle East Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
25.5. Middle East Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
25.6. Middle East Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
25.7. Middle East Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
25.8. Middle East Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
25.9. Middle East Ophthalmology Drugs Market Metrics
25.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Middle East Major Countries
25.10. Middle East Ophthalmology Drugs Market: Country Analysis
25.11. Israel Ophthalmology Drugs Market
25.12. Israel Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
25.13. Israel Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
25.14. Saudi Arabia Ophthalmology Drugs Market
25.15. Saudi Arabia Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
25.16. Saudi Arabia Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
25.17. Turkey Ophthalmology Drugs Market
25.18. Turkey Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
25.19. Turkey Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
25.20. UAE Ophthalmology Drugs Market
25.21. UAE Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
25.22. UAE Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

26. Africa Ophthalmology Drugs Market
26.1. Africa Ophthalmology Drugs Market Overview
26.1.1. Region Information
26.1.2. Market Information
26.1.3. Background Information
26.1.4. New Drug Approvals
26.1.5. Government Initiatives
26.1.6. Regulations
26.1.7. Regulatory Bodies
26.1.8. Major Associations
26.1.9. Taxes Levied
26.1.10. Corporate Tax Structure
26.1.11. Major Companies
26.2. Africa Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
26.3. Africa Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
26.4. Africa Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
26.5. Africa Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
26.6. Africa Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
26.7. Africa Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
26.8. Africa Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
26.9. Africa Ophthalmology Drugs Market Metrics
26.9.1. Per Capita Average Ophthalmology Drugs Expenditure, 2019, Africa Major Countries
26.10. Africa Ophthalmology Drugs Market: Country Analysis
26.11. Egypt Ophthalmology Drugs Market
26.12. Egypt Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
26.13. Egypt Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
26.14. Nigeria Ophthalmology Drugs Market
26.15. Nigeria Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
26.16. Nigeria Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
26.17. South Africa Ophthalmology Drugs Market
26.18. South Africa Ophthalmology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
26.19. South Africa Ophthalmology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

27. Global Ophthalmology Drugs Market Competitive Landscape
27.1. Company Profiles
27.2. Novartis AG
27.2.1. Company Overview
27.2.2. Products And Services
27.2.3. Business Strategy
27.2.4. Financial Overview
27.3. Regeneron Pharmaceuticals Inc.
27.3.1. Company Overview
27.3.2. Products And Services
27.3.3. Business Strategy
27.3.4. Financial Overview
27.4. Allergan Plc.
27.4.1. Company Overview
27.4.2. Products And Services
27.4.3. Business Strategy
27.4.4. Financial Overview
27.5. Bayer AG
27.5.1. Company Overview
27.5.2. Products And Services
27.5.3. Business Strategy
27.5.4. Financial Overview
27.6. Santen Pharmaceutical Co. Ltd.
27.6.1. Company Overview
27.6.2. Products And Services
27.6.3. Business Strategy
27.6.4. Financial Overview

28. Ophthalmology Drugs Market, Key Mergers And Acquisitions
28.1. Stada Arzneimittel AG Acquired Biopharma LLC
28.2. Fidia Farmaceutici S.P.A. Acquired Ophthalmic Products From Novartis Farma Spain
28.3. Immunovant Sciences Ltd. Merged With Health Sciences Acquisitions Corporation
28.4. Aerie Pharmaceuticals Acquired Avizorex Pharma
28.5. Novartis Acquired Ophthalmic Solution Xiidra From Takeda Pharmaceutical
28.6. Biogen Inc. Acquired Nightstar Therapeutics Limited
28.7. AbbVie Acquired Allergan
28.8. Alcon Acquired Tear Film Innovations, Inc.
28.9. Astellas Pharma Inc. Acquired Quethera Limited
28.10. TWi Pharmaceuticals, Inc. Acquired Synpac-Kingdom Pharmaceutical Co Ltd (SKP)
28.11. Chengdu Kanghong Pharma Acquired IOPtima Ltd. From BioLight
28.12. Horizon Therapeutics Plc Acquired River Vision Development Corp.
28.13. Novartis Acquired Encore Vision
28.14. Astellas Pharma Inc. Acquired Ocata Therapeutics
28.15. Purdue Canada Acquired Merck’s Ophthalmology Portfolio
28.16. Sun Pharmaceutical Industries Limited Acquired InSite Vision Inc.
28.17. Actavis Plc. Acquired Allergan Inc.
28.18. Santen Pharmaceutical Co., Ltd. Acquired Merck’s Ophthalmology Products
28.19. Lupin Limited Acquired Laboratorios Grin

29. Market Background: Pharmaceutical Drugs Market
29.1. Pharmaceutical Drugs Market Characteristics
29.2. Market Segmentation By Product Type
29.3. Global Pharmaceutical Drugs Market, 2019, By Segment, Value ($ Billion)
29.4. Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast, By Segment
29.5. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
29.6. Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast, By Region

30. Global Ophthalmology Drugs Market Opportunities And Strategies
30.1. Global Ophthalmology Drugs Market In 2023 – Countries Offering Most New Opportunities
30.2. Global Ophthalmology Drugs Market In 2023 – Segments Offering Most New Opportunities
30.3. Global Ophthalmology Drugs Market In 2023 – Growth Strategies
30.3.1. Market Trend Based Strategies
30.3.2. Competitor Strategies

31. Ophthalmology Drugs Market, Conclusions And Recommendations
31.1. Conclusions
31.2. Recommendations
31.2.1. Product
31.2.2. Price
31.2.3. Place
31.2.4. Promotion

32. Appendix
32.1. Market Data Sources
32.2. NAICS Definitions Of Industry Covered In This Report
32.3. Research Methodology
32.4. Currencies
32.5. Research Inquiries
32.6. About the Publisher
33. Copyright and Disclaimer

Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Adcock Ingram
  • Cristalia
  • ERC Labs
  • Johnson & Johnson
  • Pfizer Inc.
  • Shire

This report describes and evaluates the global ophthalmology drugs market. It covers 2015 to 2019, termed the historic period, and 2019 to 2023 termed the forecast period, along with further forecasts for the periods 2023-2025 and 2025-2030.

The global ophthalmology drugs market is expected to decline from $24,640.0 million in 2019 to $19,831.3 million in 2020 at a compound annual growth rate (CAGR) of -19.5%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 44.6% from 2021 and reach $33,272.8 million in 2023. The market is expected to grow at a CAGR of 7.2% to nearly $38,223.53 million by 2025, and at a CAGR of 7.0% to $53,698.87 million by 2030.

Growth in the historic period resulted from the aging population prone to age-related eye disorders, the increase in number of contact lens users suffering from dry eye condition, increased funding from public and private research organizations, increased healthcare expenditure globally, increase in allergy diseases (hay fever) and increase in number of treatment options. Factors that negatively affected growth in the historic period were low healthcare access, particularly in developing countries, and lack of awareness about eye disorders such as dry eye and glaucoma.

Going forward, rise in laser surgeries, digitalization of the workplace, increasing prevalence of eye-related disorders and increasing geriatric population, growing burden of diabetes and other comorbidities, side effects of other medication, and promising pipeline for dry eye disease will drive growth. Factors that could hinder the growth of the ophthalmology drugs market in the future include long and costly drug approval procedures, inadequate insurance coverage of ophthalmologists’ services expiration of branded drug patents and disruption in the supply chain of ophthalmology drugs due to the impact of COVID-19.

The ophthalmology drugs market is segmented by type of drug into antiglaucoma drugs, dry eye medication and other ophthalmology drugs used to treat retinal disorders, infections and allergies. The other ophthalmology drugs segment was the largest segment of the ophthalmology drugs market in 2019 at 58.1% or $14,320.7 million. It is expected to be the fastest-growing segment going forward at a CAGR of 9.1%.

The ophthalmology drugs market is segmented by distribution channel into hospital pharmacies, eye health clinics, retail pharmacies and online pharmacies. The retail pharmacies segment was the largest segment of the ophthalmology drugs market in 2019 at 63.0% or $15,530.8 million. Going forward, the online pharmacies are expected to be the fastest-growing segment going forward at a CAGR of 15.4%.

The ophthalmology drugs market is segmented by type of prescription into Over-The-Counter (OTC) drugs and prescription drugs. The OTC drugs segment was the largest segment of the ophthalmology drugs market in 2019 at 54.1% or $13,323.5 million. Going forward, the prescription drugs are expected to be the fastest-growing segment going forward at a CAGR of 9.9%.

The ophthalmology drugs market is segmented by drug variation into branded drugs and generic drugs. The branded drugs segment was the largest segment of the ophthalmology drugs market in 2019 at 50.8% or $12,517.1 million. Going forward, the generic drugs is expected to be the fastest-growing segment going forward at a CAGR of 9.7%.

North America was the largest region in the global ophthalmology drugs market, accounting for 41.4% of the total in 2019. It was followed by Asia-Pacific, Western Europe, South America, and then the other regions. Going forward, the fastest-growing regions in the ophthalmology drugs market will be North America and the Asia Pacific, where growth will be at CAGRs of 8.9% and 8.5% respectively. These will be followed by the Middle East, Africa where the markets are expected to grow at CAGRs of 7.0% and 6.9% respectively.

The ophthalmology drugs market is highly concentrated, with a small number of large players. The top ten competitors in the market made up to 88.0% of the total market in 2019. Major players in the market include Novartis AG, Regeneron Pharmaceuticals Inc., Allergan Plc., Bayer AG, and Santen Pharmaceutical Co. Ltd.

The global pharmaceutical drugs market, of which the ophthalmology drugs market is a segment, reached a value of nearly $936.3 billion in 2019, having grown at a CAGR of 3.9% since 2015. It is expected to grow at a CAGR of 8.5% to nearly $1,298.6 billion by 2023. The ophthalmology drugs market was the smallest segment of the pharmaceutical drugs market accounting for 2.6% of the total in 2019. The dermatology drugs segment is expected to be the fastest-growing segment in the pharmaceutical drugs market, growing at a CAGR of 13.0% during 2019-2023.

The top opportunities in the ophthalmology drugs market segmented by type of drug will arise in the other ophthalmology drugs segment, which will gain $5,975.5 million of global annual sales by 2023. The top opportunities in the ophthalmology drugs market segmented by distribution channel will arise in the retail pharmacies segment, which will gain $4,580.4 million of global annual sales by 2023. The top opportunities in the ophthalmology drugs market segmented by prescription type will arise in the prescription drugs segment, which will gain $5,216.39 million of global annual sales by 2023. The top opportunities in the ophthalmology drugs market segmented by drug variation will arise in the generic drugs segment, which will gain $5,430.37 million of global annual sales by 2023.

The ophthalmology drugs market size will gain the most in the USA at $3,838 million. Market-trend-based strategies for the ophthalmology drugs market include develop innovative drugs, develop drugs with rho-kinase inhibitors to make the glaucoma drugs more effective, develop preservative-free eye drops for the treatment of dry-eye syndrome, develop new mode of delivery systems for the treatment of dry-eye syndrome, invest in research and development of new and advanced drugs, develop non-steroidal anti-inflammatory ophthalmic drugs, develop combination therapies and consider acquiring smaller companies to diversify their product portfolio. Player-adopted strategies in the ophthalmology drugs market include expanding through acquisitions, expanding its ophthalmic products to newer geographies by obtaining drug approvals from regulatory authorities, and aim at building diverse ophthalmology portfolio with a pipeline of drugs.

The outbreak of Coronavirus has caused a shortage in the supply of ophthalmic drugs for the treatment of dry eyes. This is because the COVID-19 pandemic created disruption in the global pharmaceutical supply chain which is heavily dependent on China. The main raw materials in drug production are manufactured in China and are exported to other parts of the world for making the final drug. This has resulted in pharmacies and wholesalers reporting many drugs being out of stock. Owing to the shortage of medications, governments are advising pharmacists to limit the dispensing of certain dry eye prescription medicines such as chloramphenicol (an antibiotic for conjunctivitis) eye drops and ointments to a one-month supply according to the prescribed dose. Also, pharmacists are recommended to sell certain over the counter medicines (OTC) to a maximum of one unit per purchase due to the concern on the significant health impacts on the patients that can be caused due to the shortage of medicines during this pandemic.

Note: Product cover images may vary from those shown
  • Adcock Ingram
  • Aflofarm Farmacja Polska Sp. z o. o,
  • Akron Inc.
  • Alcon Pharmaceuticals Czech Republic S.r.o.
  • Aurinia Pharmaceuticals Inc
  • Bausch Health Companies Inc.
  • Biolab Farmaceutica
  • Cristalia
  • Daiichi Sankyo
  • Endo International plc
  • ERC Labs
  • F. Hoffmann-La Roche Ltd.
  • Herzig Eye Institute
  • Implandata ophthalmic products GmbH
  • Johnson & Johnson
  • Medicom Health care
  • Novamedika
  • Otsuka Pharmaceutical Co. Ltd
  • Pfizer Inc.
  • Regenerx Biopharmaceuticals Inc
  • ReGenTree, LLC
  • Shanghai Pharmaceuticals
  • Shire
  • Sun Pharmaceutical Industries Limited
  • Teuto Brasileiro
  • The Geuder Group, MORCHER® GmbH
  • Thomas Eye Group
  • Vision gain
  • VUAB Pharma, Inc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll